PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia
Eye (Lond)
.
2024 Dec 2.
doi: 10.1038/s41433-024-03523-1.
Online ahead of print.
Authors
Maria S Varughese
1
,
Ananth U Nayak
2
3
,
Sarita Jacob
4
5
6
7
Affiliations
1
University of Sheffield Medical School, Royal Hallamshire Hospital, Sheffield, UK.
2
University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, North Staffordshire, UK.
3
School of Medicine, Faculty of Health, Keele University, Newcastle, North Staffordshire, UK.
4
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
[email protected]
.
5
Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
[email protected]
.
6
College of Life and Health Sciences, Aston University, Birmingham, UK.
[email protected]
.
7
Birmingham, Solihull and Black Country Diabetic Eye Screening Programme, Birmingham, UK.
[email protected]
.
PMID:
39623109
DOI:
10.1038/s41433-024-03523-1
No abstract available